UCL and Syncona have both returned for Freeline's series B round, which will spur clinical development of the spinout's gene therapy for haemophilia B.

Existing investor FoxKiser has returned for a $32.5m round that follows the cancer immunotherapy T cell developer's series A two years ago.

Wearable sleep tracking device manufacturer Onera has raised an undisclosed sum after spinning off from TNO and nanoelectronics maker Imec.

Calibrate Ventures has led a $22m series A in Embodied, a robotics developer co-founded by USC professor Maja Matari.

The three investees include regenerative cardiovascular medicine developer CorMatrix, which had previously raised a total of $38.5m in funding.

The radiation therapy system provider has now raised more than $500m altogether, having received funding from backers including Henan Maisheng.

Venture V, whose limited partners include the European Investment Fund, will invest in spinouts from Sintef and NTNU.